Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (261-270 of 403) with videos related to

Pageof 41
Sort By:
The Pediatric Infectious Disease Journal|June 16, 2015
Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool AgeDavid A Ishola, Nick Andrews, Pauline Waight, et al.
Vaccine|December 17, 2014
Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation scheduleShamez N Ladhani, Nick J Andrews, Pauline Waight, et al.
Infection and Immunity|August 17, 2002
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protectionMoya Burrage, Andrew Robinson, Ray Borrow, et al.
Clinical and Vaccine Immunology : CVI|June 26, 2009
Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesiclesAndrew R Gorringe, Stephen Taylor, Charlotte Brookes, et al.
HIV Medicine|November 28, 2023
Propositive follow-up: Long-term immune responses to the 4CMenB and MenACWY vaccines in people living with HIVAlberto San Francisco Ramos, Catherine Isitt, Shehnaz Athaide, et al.
The Pediatric Infectious Disease Journal|September 17, 2010
Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trialMatthew D Snape, Tom Dawson, Philipp Oster, et al.
The Journal of Infection|August 29, 2020
Geographically widespread invasive meningococcal disease caused by a ciprofloxacin resistant non-groupable strain of the ST-175 clonal complexLaura Willerton, Jay Lucidarme, Helen Campbell, et al.
Clinical and Vaccine Immunology : CVI|January 27, 2012
Human papillomavirus antibody reference reagents for use in postvaccination surveillance serologySara L Bissett, Dianna Wilkinson, Kate I Tettmar, et al.
The New England Journal of Medicine|July 29, 2016
Immunogenicity of a Meningococcal B Vaccine during a University OutbreakNicole E Basta, Adel A F Mahmoud, Julian Wolfson, et al.
Infection and Immunity|November 22, 2005
Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed with chitosanZhiming Huo, Ruchi Sinha, Edel A McNeela, et al.
Pageof 41

Showing results (261-270 of 403) with videos related to

Sort By:
Pageof 41
The Pediatric Infectious Disease Journal|June 16, 2015
Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool AgeDavid A Ishola, Nick Andrews, Pauline Waight, et al.
Vaccine|December 17, 2014
Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation scheduleShamez N Ladhani, Nick J Andrews, Pauline Waight, et al.
Infection and Immunity|August 17, 2002
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protectionMoya Burrage, Andrew Robinson, Ray Borrow, et al.
Clinical and Vaccine Immunology : CVI|June 26, 2009
Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesiclesAndrew R Gorringe, Stephen Taylor, Charlotte Brookes, et al.
HIV Medicine|November 28, 2023
Propositive follow-up: Long-term immune responses to the 4CMenB and MenACWY vaccines in people living with HIVAlberto San Francisco Ramos, Catherine Isitt, Shehnaz Athaide, et al.
The Pediatric Infectious Disease Journal|September 17, 2010
Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trialMatthew D Snape, Tom Dawson, Philipp Oster, et al.
The Journal of Infection|August 29, 2020
Geographically widespread invasive meningococcal disease caused by a ciprofloxacin resistant non-groupable strain of the ST-175 clonal complexLaura Willerton, Jay Lucidarme, Helen Campbell, et al.
Clinical and Vaccine Immunology : CVI|January 27, 2012
Human papillomavirus antibody reference reagents for use in postvaccination surveillance serologySara L Bissett, Dianna Wilkinson, Kate I Tettmar, et al.
The New England Journal of Medicine|July 29, 2016
Immunogenicity of a Meningococcal B Vaccine during a University OutbreakNicole E Basta, Adel A F Mahmoud, Julian Wolfson, et al.
Infection and Immunity|November 22, 2005
Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed with chitosanZhiming Huo, Ruchi Sinha, Edel A McNeela, et al.
Pageof 41